Skip to content

IQVIA IQV Equity Method Income

Equity Method Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$8M+42.9%
Labcorp Holdings logo
Labcorp HoldingsLH
-$5.1M-1,600%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-$3.09M-63.9%
Cognizant logo
CognizantCTSH

Other financials

Income statement

See full
Revenue$4.2B+8.4%
Gross profit$1.4B+4.4%
Operating income$514.0M+3.6%
Net income$274.0M+10.0%
EPS (diluted)$1.61+15.0%

Balance sheet

See full
Cash & equivalents$1.9B+11.9%
Total debt$16.1B+10.7%
Total equity$6.2B+4.1%
Total assets$29.7B+8.6%

Cash flow

See full
Operating cash flow$618.0M+8.8%
CapEx$127.0M-10.6%
Free cash flow$491.0M+15.3%

Valuation

See full
Market cap$32.25B+26.3%
Enterprise value$46.37B+18.6%
P/E23.3×+2.6×
P/S1.9×+0.3×

Profitability

See full
Gross margin33%-1.7pp
Operating margin13.2%-0.9pp
Net margin8.3%-0.3pp
FCF margin12.7%-1.2pp

Returns & leverage

See full
Return on equity22.7%+1.1pp
Debt / equity2.6×+0.2×
Current ratio0.7×-0.1×

Where this comes from

Reported directly by IQVIA in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: IQVIA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IQVIA's equity method income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IQVIA's equity method income?
IQVIA (IQV) reported equity method income of $6M in Q1 2026.
How has IQVIA's equity method income changed year-over-year?
IQVIA's equity method income increased by 146.2% year-over-year, from -$13M to $6M.
What is the long-term trend for IQVIA's equity method income?
Over 4 years (2021 to 2025), IQVIA's equity method income has grown at a 38.4% compound annual growth rate (CAGR), from $6M to $22M.
What does equity method income mean?
The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.